Skip to content

Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscle

Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscle - Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscle

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029803
Enrollment
10
Registered
2017-11-02
Start date
2017-11-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower back pain patients with frailty/sarcopenia, or having muscle weakness in their previous stage

Interventions

Body trunk and squat training as many times as possible with HAL-CB02 for 30 minutes per day. The above training is performed for 5 days during weekdays. We assesse and compare at pre and post HAL-CB

Sponsors

Fukuoka University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients signed an informed consent document 2.Patients with lumbago 3.Patients diagnosed with frailty or sarcopenia

Exclusion criteria

Exclusion criteria: 1. Patients with severe cognitive impairment or mental illness 2. Patients disable to wear the device because of the body size or so 3. Patients enrolled to the other clinical study 4. Patients ineligible to the study based on investigator`s decision 5. Patients who take no proper treatment of lumber spinal canal stenosis, hernia or other diseases which could be a cause for lumbago 6. Patients with vertebral fractures or lower limb fractures developed in 6 months 7. Patients with coxarthrosis 8. Patients with poor general condition such as heart failure 9. Bedridden patients 10. Patients who need treatment of the other disease prior to frailty or sarcopenia caused by lumbago

Design outcomes

Primary

MeasureTime frame
Pain evaluation by VAS, RDQ and SF-MPQ-2,10m walk, Timed Up and Go Test

Secondary

MeasureTime frame
Analysis for factors to relate the efficacy of HAL-CB02-assisted training: Gender, age, height, weight, grip strength, lower limb circumference, posture measurement, complicated spinal or spine disease analyzed by CT and muscle cross-sectional area (paravertebral muscle, quadriceps femoris muscle) estimated by CT

Countries

Japan

Contacts

Public ContactTakashi Morishita

Fukuoka University Hospital Department of Neurosurgery

tmorishita@fukuoka-u.ac.jp092-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026